FRAS1 (Fraser syndrome protein 1), together with FREM1 (the Fras1-related extracellular matrix proteins 1) and FREM2, belonging to the FRAS1/FREM extracellular matrix protein family, are considered to play essential roles in renal organogenesis and cancer progression. However, their roles in kidney renal clear cell carcinoma (KIRC) remain to be elucidated. FRAS1/FREM RNA expression analysis was performed using TCGA/GTEx databases, and valided using GEO databases and real-time PCR. Protein expression was peformed using CPTAC databases. Herein, we employed an array of bioinformatics methods and online databases to explore the potential oncogenic roles of FRAS1/FREM in KIRC. We found that FRAS1, FREM1 and FREM2 genes and proteins expression levels were significantly decreased in KIRC tissues than in normal tissues. Decreased FRAS1/FREM expression levels were significantly associated with advanced clinicopathological parameters (pathological stage, grade and tumor metastasis status). Notably, the patients with decreased FRAS1/FREM2 expression showed a high propensity for metastasis and poor prognosis. FRAS1/FREM were correlated with various immune infiltrating cells, especially CD4 T cells and its corresponding subsets (Th1, Th2, Tfh and Tregs). FRAS1 and FREM2 had association with DNA methylation and their single CpG methylation levels were associated with prognosis. Moreover, FRAS1/FREM might exert antitumor effects by functioning in key oncogenic signalling pathways and metabolic pathways. Drug sensitivity analysis indicated that high FRAS1 and FREM2 expression can be a reliable predictor of targeted therapeutic drug response, highlighting the potential as anticancer drug targets. Together, our results indicated that FRAS1/FREM family members could be potential therapeutic targets and valuable prognostic biomarkers of KIRC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558830 | PMC |
| http://dx.doi.org/10.3389/fphar.2022.972934 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma.
Front Pharmacol
September 2022
Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
FRAS1 (Fraser syndrome protein 1), together with FREM1 (the Fras1-related extracellular matrix proteins 1) and FREM2, belonging to the FRAS1/FREM extracellular matrix protein family, are considered to play essential roles in renal organogenesis and cancer progression. However, their roles in kidney renal clear cell carcinoma (KIRC) remain to be elucidated. FRAS1/FREM RNA expression analysis was performed using TCGA/GTEx databases, and valided using GEO databases and real-time PCR.
View Article and Find Full Text PDFThe Metabolic Reprogramming of Mutant Mice Embryos in Cryptophthalmos Development.
Front Cell Dev Biol
January 2021
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
Background: Cryptophthalmos is characterized by congenital ocular dysplasia with eyelid malformation. The pathogenicity of mutations in genes encoding components of the FRAS1/FREM protein complex is well established, but the underlying pathomechanisms of this disease are still unclear. In the previous study, we generated mice carrying compound heterozygous mutations using CRISPR/Cas9 and showed that these mice recapitulated the human cryptophthalmos phenotype.
View Article and Find Full Text PDFCharacteristic dental pattern with hypodontia and short roots in Fraser syndrome.
Am J Med Genet A
July 2020
Institute of Human Genetics, University Hospital, Magdeburg, Germany.
Fraser syndrome (FS) is a rare autosomal recessive multiple congenital malformation syndrome characterized by cryptophthalmos, cutaneous syndactyly, renal agenesis, ambiguous genitalia, and laryngotracheal anomalies. It is caused by biallelic mutations of FRAS1, FREM2, and GRIP1 genes, encoding components of a protein complex that mediates embryonic epithelial-mesenchymal interactions. Anecdotal reports have described abnormal orodental findings in FS, but no study has as yet addressed the orodental findings of FS systematically.
View Article and Find Full Text PDFSegmental and restricted localization pattern of Fras1 in the developing meningeal basement membrane in mouse.
Histochem Cell Biol
November 2013
Department of Biology, University of Crete, Voutes University Campus, 700 13, Heraklion, Crete, Greece.
Article Synopsis
- The Fras1/Frem family of proteins, including Fras1, Frem1, Frem2, and Frem3, are important for epithelial-mesenchymal adhesion during embryonic development, primarily found in basement membranes.
- Recent research revealed that Fras1 is specifically located in the meningeal basement membrane of the developing mouse brain, showing a segmental distribution pattern.
- The presence of Fras1 and Frem2 in areas near organizing centers like the roof plate suggests their potential involvement in signaling processes, indicating that there may be functional and structural differences within the meningeal basement membrane.
Mutations in GRIP1 cause Fraser syndrome.
J Med Genet
May 2012
Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
Background: Fraser syndrome (FS) is a autosomal recessive malformation syndrome characterised by cryptophthalmos, syndactyly and urogenital defects. FS is a genetically heterogeneous condition. Thus far, mutations in FRAS1 and FREM2 have been identified as cause of FS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!